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Mercury (Hg) toxicity is the focus of substan‑
tial public concern. Pronouncements about 
the safety of fish in the diet and about adverse 
health effects attributable to dental amalgams 
are the primary bases underlying this concern. 
Hg occurs in different forms in the environ‑
ment; Hg species are classified as elemental 
(Hg0), inorganic (Hg2+, Hg+), and organic 
[e.g., methylmercury (MeHg)]. However, 
many populations are exposed to more than 
one form. Almost all of our knowledge is based 
on research devoted to only one Hg species. 
How different species of Hg act in combina‑
tion remains unclear, which leads to significant 
gaps in our understanding of Hg toxicity.
MeHg, to which humans are primarily 
exposed through consumption of contami‑
nated fish, shellfish, and sea mammals [U.S. 
Environmental Protection Agency (EPA) 
1997], is a potent neuro  toxicant to both the 
mature and developing central nervous system. 
Several studies have shown potential adverse 
effects on child development from prenatal 
exposure to MeHg (for review, see Clarkson 
and Magos 2006). Observations in human 
populations demonstrate that MeHg readily 
crosses the placental barrier, as indicated by 
cord blood levels higher than those seen in 
maternal blood (Vahter et al 2000). MeHg 
can penetrate into the fetal brain (Aschner and 
Aschner 1990; Choi et al. 1978; Davis et al. 
1994; Day et al. 2005; Newland et al. 2006; 
Newland and Reile 1999; Stern et al. 2001), 
which allows for accumulation in the central 
nervous system. Because MeHg is slowly con‑
verted to inorganic Hg in brain tissue, and as 
such resides there for many years (Charleston 
et al. 1995; Davis et al. 1994), the relative con‑
tribution of the intact organomercurial versus 
the inorganic metabolite to neuronal damage 
remains an open question (Magos 1987), with 
significant implications for risk assessment.
Another major source of Hg exposure 
is inorganic Hg in the form of Hg vapor. 
Exposure of the general population to Hg 
vapor occurs primarily through inhala‑
tion of Hg vapor released from dental amal‑
gams [Brownawell et al. 2005; International 
Programme on Chemical Safety (IPCS) 1991]. 
Although the levels from such exposures are 
considered “low” with respect to some known 
health effects, we know little about how those 
exposures might interact with MeHg toxicity. 
Approximately 80% of inhaled Hg vapor is 
retained and absorbed in blood during pulmo‑
nary circulation (Hursh et al. 1976). Although 
Hg vapor introduced into the body is trapped 
and oxidized to divalent inorganic Hg in 
erythro  cytes, part of the Hg vapor remains in 
the bloodstream long enough for it to be dis‑
tributed to other tissues and reach the blood–
brain barrier (Yoshida 2002). Non‑ionized 
Hg readily penetrates the placental barrier 
(Clarkson et al. 1972; Khayat and Dencker 
1982) and is taken up by fetal tissues, including 
brain. The ability of inhaled Hg vapor to accu‑
mulate in the fetal brain has also been shown 
in human and animal studies (Drasch et al. 
1994; Morgan et al. 2002, 2006). Inhaled Hg 
vapor has been known to damage the adult 
central nervous system (Echeverria et al. 1998; 
Goldwater 1972). On the other hand, only a 
limited number of studies have shown behav‑
ioral changes in animals prenatally exposed to 
Hg vapor (Danielsson et al. 1993; Fredriksson 
et al. 1996). However, the study designs of 
these experiments were not rele  vant to human 
exposure because of rather high concentrations 
of Hg vapor and short durations of exposure.
Although studies of combined exposures 
are limited, we do know that both agents 
a) produce prenatal damage; b) produce 
behavioral changes in animals at levels that do 
not produce clinically apparent toxicity; and 
c) result in deposition in the brain of the same 
toxic species of Hg, namely, mercuric Hg. Yet 
there are reasons to suggest that combined 
exposure to MeHg and inhaled Hg vapor 
might produce effects different from those seen 
from exposure to either agent alone: 
• MeHg is well known to affect the develop‑
ing central nervous system, whereas effects of 
inhaled Hg vapor on that system are not clear.
• Metabolism of MeHg differs from that of 
Hg vapor (Clarkson and Magos 2006). 
• Brain pathology and the signs and symp‑
toms of MeHg poisoning differ from those 
of inorganic Hg poisoning (Clarkson and 
Magos 2006).
• Although both MeHg and Hg vapor result 
in deposition in the brain as mercuric Hg, 
divalent inorganic Hg (Hg2+) is believed to 
be the proximate toxic agent in the case of 
poisoning from inhaled Hg vapor, but this 
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does not appear to be the case for MeHg 
(Clarkson and Magos 2006). 
• Delayed manifestation of the effects of MeHg 
is seen in humans and animals (typical exam‑
ples of latent toxicity in humans, including 
both acute and chronic MeHg exposures have 
been described) (Weiss et al. 2005a), and 
latent toxicities in animals have been shown 
(Newland and Rasmussen 2000; Newland 
et al. 2004; Rice 1996; Yoshida et al. 2008), 
but these are not known for inorganic vapor. 
Even so, despite the considerable public health 
implications of coexposure, only Fredriksson 
et al. (1996) have shown that exposure to 
MeHg can further worsen adverse behavioral 
performance compared with inhaled Hg vapor 
alone. In their experiment, rat dams were 
exposed to Hg vapor [1,800 µg Hg/m3 for 
1.5 hr/day from gestational day (GD) 14 to 
GD19), MeHg (2 mg/kg/day from GD6 to 
GD9], or both.
We designed the following experiments to 
broaden our understanding of the effects of 
joint exposure to Hg vapor and MeHg, a situa‑
tion that more realistically models human expo‑
sures, which are both concurrent and chronic 
and generally begin long before pregnancy.
Materials and Methods
Subjects. We conducted two experiments 
(experiments 1 and 2); we used the prelimi‑
nary analysis of experiment 1 to select the Hg 
doses for experi  ment 2. The basic experimen‑
tal schemes were the same between the two 
experi  ments except for the Hg doses. For the 
experiments, we used 99 (experiment 1) and 96 
(experiment 2) female Long‑Evans rats (Harlan, 
Indianapolis, IN) 8–9 weeks of age when they 
arrived at the University of Rochester Medical 
Center Vivarium (a facility certified by the 
Association for Assessment and Accreditation 
of Laboratory Animal Care). Animals were 
housed individually, in rooms maintained at 
23 ± 2°C with a 12‑hr light–dark cycle with 
light onset at 0600 hours, in polycarbonate 
breeder cages with wire covers and filter tops. 
The females were allowed free access to Teklad 
Global 2018 Rodent Diet (Harlan), which 
does not contain fish meal or animal pro‑
tein, and drinking water solutions (described 
below) except when the rats were in the expo‑
sure chambers. We chose that diet to minimize 
uncontrolled Hg contamination (Weiss et al. 
2005b). The rats were randomly assigned to 
groups as shown in Table 1. Exposure chamber 
space and exposure durations limited the num‑
ber of groups per experiment, so the 6‑ppm 
MeHg × 300 µg/m3 Hg vapor group was 
excluded in experiment 1. Long‑Evans male 
rats (Harlan), 75 retired breeders in experi‑
ment 1 and 80 rats 8–9 weeks of age in experi‑
ment 2, were received 3 weeks after the females 
and housed under the same conditions and in 
the same rooms as the females. 
All animals were treated humanely and 
with regard for alleviation of suffering. All were 
monitored daily by the research staff and per‑
sonnel from the Division of Laboratory Animal 
Medicine of the University of Rochester 
Medical Center. All experimental procedures 
were approved by the University Committee 
on Animal Research.
Exposure to Hg. Groups of rats were 
exposed to a) MeHg as MeHg chloride via 
drinking water, b) Hg vapor, or c) both MeHg 
and Hg vapor; d) a separate group was given 
Na2CO3 vehicle (controls). Exposures occurred 
daily for 30 days before breeding to attain a 
stable Hg burden in the females so as to simu‑
late the human exposure pattern. Exposures 
continued until GD18.
Hg vapor. Before beginning the exposures, 
the females were adapted for 1 week to the 
routine of being transported from their home 
quarters to the inhalation facility and placed 
in the exposure chambers. This was done to 
preclude excessive uptake of Hg during ini‑
tial exposures, which would be expected in 
the absence of adaptation (Stern et al. 1996). 
The 2‑hr exposure of female rats to Hg vapor 
was conducted in two adjacent hexagonal 
Rochester chambers (one control, one expo‑
sure), each having an internal capacity of 2 m3 
(Chen and Moss 1989). The chambers were 
supplied with filtered and conditioned outside 
air drawn into the chamber through an intake 
duct at the top and discharged into an exhaust 
manifold with an Hg‑trapping filter at the 
bottom. Chamber temperatures were main‑
tained at 22–24°C. Metallic Hg was heated in 
a flask located adjacent to the exposure cham‑
ber. Vapor concentrations were controlled by 
adjusting the flow of heated air passing over 
the Hg, which was then mixed with the main 
airstream flowing into the chamber. During 
exposure, the Hg vapor concentration was 
monitored continuously with an ultraviolet 
Hg monitor. The calibration of the monitor 
was confirmed using a Jerome 431‑X mer‑
cury vapor analyzer (Arizona Instrument 
LLC, Chandler, AZ), which was certified by 
an independent testing laboratory. The out‑
put was connected to a desktop computer for 
both online monitoring and temporary stor‑
age of sampling data files. For exposures, the 
subjects were held individually in open‑mesh 
metal cages. The 2‑hr session was designated 
as beginning when the Hg concentration 
reached 66% of the target concentration (~ 10 
min; it reached 90% of the target value in 
about an additional 1–2 min). Once attained, 
the concentration was maintained at the tar‑
get value (± 5%). At the end of the scheduled 
exposure, the Hg‑vapor generator was turned 
off, and the airflow over the Hg was stopped. 
Chamber concentration declined rapidly, 
falling to ≤ 30 µg/m3 in just a few minutes. 
The females were then removed after another 
30 min in order to completely exhaust the 
chambers. Exposure continued from 30 days 
before breeding through GD18.
MeHg. The females were dosed with an 
MeHg chloride (CH3HgCl) drinking solu‑
tion 30 days before breeding through GD18. 
For dosing, we prepared 100 ppm MeHg 
stock solution weekly by dissolving crystal‑
line CH3HgCl (Alfa Aesar, Ward Hill, MA) 
in a buffer solution of 5 mM sodium car‑
bonate (Na2CO3; Mallinckrodt & Baker, 
Inc., Phillipsburg, NJ). The stock solution 
was diluted to produce requisite quantities of 
the dosing solutions. The Na2CO3 solution 
was also used for the 0‑ppm control group. 
Solutions were stored in glass bottles with 
neoprene stoppers and stainless steel spouts. 
MeHg concentration was confirmed by 
cold vapor atomic absorption spectrometry 
and found to be within 5% of the target value.
Breeding and litters. After 30 days of 
exposure, individual females were randomly 
placed with the males at 1600–1700 hours. 
The female’s drinking solution was always kept 
on the cage in which she was located, so it was 
on the breeding cage only when she was physi‑
cally present with the male. Vaginal smears 
were obtained at 0600 hours and examined 
microscopically for the presence of sperm, and 
the female was then returned to her home 
cage. The day a sperm‑positive smear was 
observed was defined as GD0. A male was 
paired with the same female(s) until a sperm‑
positive smear was observed, or after three 
successive nights, whichever came first. Some 
males were paired with a second female, which 
was always a member of a different exposure 
group. Immediately after the Hg vapor expo‑
sure on GD18, blood was drawn from the 
tail of four females in each group into hepa‑
rinized calibrated micropipets (Drummond 
Scientific Co., Broomall, PA). Blood samples 
were stored in 0.9% NaCl (Sigma‑Aldrich, St. 
Louis, MO) at 4°C until assayed. 
The day on which a litter was discovered 
(up to 1300 hours) was designated as post‑
natal day (PND) 1. Litter size and sex, body 
weight, and overall health status of each pup 
were checked and recorded. 
Table 1. Group assignment in the two experiments.
MeHg (ppm)
Hg vapor (µg/m3) 0 3 6 9
Experiment 1
0 15a 12a 12a
300 12 12
1,000 12a 12a 12a
Experiment 2
0 12a 12a 12a 12
1,000 12a 12a 12a 12
Values shown are the number of females assigned to each 
group at the beginning of the experiments. In experiment 1, 
the 6‑ppm MeHg × 300 µg/m3 Hg vapor group was pre‑
cluded because exposure chamber space and exposure 
durations limited the number of groups per experiment.
aGroup included in both experiments. Ishitobi et al.
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On PND4, litters were culled via random 
sampling to three pups of each sex per litter in 
experiment 1 and four in experiment 2. For 
culling, pups were separated by sex and then 
separated, held individually in a fixed order, 
and weighed. A pup was culled immediately if 
its weight fell below 75% of the mean for that 
sex in that litter, unless needed for brain sam‑
pling. Then, after a list of random numbers 
equal to the number of remaining pups for 
that litter/sex, pups were kept or culled.
Brains were sampled on PND4 from one 
male and one female litter  mate from each of 
four litters in each group. Some brains were 
collected from pups weighing < 75% of the 
mean for that sex in that litter. Pups were 
sacrificed after carbon dioxide anesthesia, and 
the whole brain was removed and weighed. 
The brains were stored at –12°C until assayed. 
Hg assays. We determined Hg levels in 
brain and blood by cold vapor atomic absorp‑
tion spectrophotometry using a flameless 
atomic absorption monitor (model 1235; 
Laboratory Data Control, Riviera Beach, FL). 
All details of analysis and sample prepara‑
tion have been previously described (Magos 
1971; Magos and Clarkson 1972). The 
method is based on the rapid conversions of 
Hg compounds into atomic Hg. Cadmium 
chloride/stannous chloride reagent is used 
to reduce total Hg (organic plus inorganic), 
whereas stannous chloride selectively reduces 
inorganic Hg. Organic Hg is the difference 
between total and inorganic Hg. We deter‑
mined Hg in brain after digestion with 40% 
sodium hydroxide, and in blood after sample 
dilution with saline. For standards prepara‑
tion, we used Mercury Reference Standard 
Solution (SM 114‑100; Fisher Scientific, 
Fairmont, NJ). Detection limits (LODs) and 
quantification limits were calculated from 
blank measurements following the recom‑
mendations of the International Union of Pure 
and Applied Chemistry (Currie 1999). The 
LODs (3 × SD for blanks) were 19.5 ng/g for 
total Hg, 9.75 ng/g for inorganic Hg for brain, 
and 11.5 µg/L for both total and inorganic Hg 
for blood, whereas limits of quantification were 
65.0 ng/g, 32.5 ng/g, and 38.3 µg/L, respec‑
tively. For samples with values < LOD, we 
used one‑half the LOD for statistical analysis. 
The method imprecision, calculated as the coef‑
ficient of variation for duplicate preparations 
measurements, was 4%. We evaluated the ana‑
lytical accuracy of Hg determination using ref‑
erence material (certified human blood samples 
from the Centre de Toxicologie du Quebec, 
International Comparison Program, Quebec, 
Canada). Our result was 76.65 ± 1.41 ng/g for 
lot M‑08‑14, compared with 79 ng/g (range, 
58–100 ng/g) the results from the Centre de 
Toxicologie du Quebec. Participation in exter‑
nal quality control programs also rendered 
highly satis  factory data.
Statistical analysis. Breeding outcomes and 
Hg in dam’s blood. For breeding outcomes, 
we used the litter as the unit for analysis, and 
for dam’s blood, we used the dam. We evalu‑
ated outcomes (of the averaged parameters if 
needed for the breeding outcomes) using one‑
way analysis of variance (ANOVA) to deter‑
mine differences among groups (defined by Hg 
vapor and MeHg concentrations), and using 
two‑way ANOVA to determine the effects of 
MeHg, Hg vapor, and their interaction. Values 
of p < 0.05 were considered statistically signifi‑
cant. We used a logarithmic (base e) transfor‑
mation of many outcomes in order to satisfy 
model assumptions.
Models for pup’s brain Hg. We applied 
linear mixed‑effects models (McCulloch and 
Searle 2001) using R software (Faraway 2006; 
see also R Foundation for Statistical Computing 
2009) to examine the relations among MeHg 
dose, Hg vapor dose, sex, experiment, and two 
outcomes: organic and inorganic Hg brain 
levels. The two outcomes were examined in 
Table 2. Number of litters, number of pups per litter, and body weight (mean ± SD) on PND1 and PND4 in experiment 1.
Group [MeHg (ppm) × Hg vapor (µg/m3)]
0 × 0 3 × 0 6 × 0 0 × 300 3 × 300 0 × 1,000 3 × 1,000 6 × 1,000
No. of litters
PND1 14 10 10 12 10 10 9 11
PND4 14 10 9 12 10 10 9 11
No. of pups per litter
PND1 10.8 11.7 8.4 11.8 11.9 10.7 10.4 11.1
PND4 10.8 11.6 9.2 11.8 11.5 9.3 10.1 10.7
Body weight (g)
Males
PND1 6.40 ± 0.07 6.34 ± 0.11 6.61 ± 0.14 6.21 ± 0.16 6.10 ± 0.16 6.47 ± 0.14 6.32 ± 0.11 6.48 ± 0.21
PND4 9.44 ± 0.80 9.11 ± 0.96 9.85 ± 1.24 9.07 ± 1.27 8.92 ± 0.85 8.94 ± 1.17 9.09 ± 1.19 9.55 ± 1.72
Females
PND1 6.11 ± 0.10 6.06 ± 0.09 6.10 ± 0.11 5.92 ± 0.13 5.82 ± 0.17 6.11 ± 0.11 6.01 ± 0.08 6.19 ± 0.16
PND4 9.02 ± 0.67 8.66 ± 1.03 9.36 ± 1.16 8.65 ± 1.11 8.52 ± 1.04 8.38 ± 1.61 8.45 ± 1.32 9.10 ± 1.41
Group means were calculated using the mean litter weight per group per day. Body weight on PND1 did not differ among groups. 
Table 3. Number of litters, number of pups per litter, and body weight (mean ± SD) on PND1 and PND4 in experiment 2.
Group [MeHg (ppm) × Hg vapor (µg/m3)]
0 × 0 3 × 0 6 × 0 9 × 0 0 × 1,000 3 × 1,000 6 × 1,000 9 × 1,000
No. of litters
PND1 10 11 7 11 10 10 8 11
PND4 10 11 7 7 10 9 8 9
No. of pups per litter
PND1 9.4 10.7 8.1 10.9 11.4 10.2 11.3 8.1
PND4 9.2 10.6 7.4 12.6 10.3 11.1 7.8 6.8
Body weight (g)
Males
PND1 6.42 ± 0.56 6.28 ± 0.26 6.53 ± 0.52 5.89 ± 0.64 6.05 ± 0.42 6.22 ± 0.78 5.96 ± 0.49 6.07 ± 0.65
PND4 9.03 ± 1.37 8.87 ± 0.54 9.15 ± 0.85 7.33 ± 0.58 8.58 ± 1.47 9.18 ± 0.80 8.20 ± 1.97 8.20 ± 1.58
Females
PND1 6.05 ± 0.46 5.94 ± 0.25 6.10 ± 0.62 5.59 ± 0.62 5.73 ± 0.46 6.07 ± 0.42 5.69 ± 0.78 5.71 ± 0.55
PND4 8.73 ± 1.17 8.40 ± 0.60 8.45 ± 1.20 7.17 ± 0.92 8.12 ± 1.32 8.47 ± 0.93 7.47 ± 2.60 7.06 ± 1.53
Group means were calculated using the mean litter weight per group per day. More pups were lost in the 9‑ppm MeHg groups with or without Hg vapor exposure between PND1 and 
PND4. Body weight on PND1 did not differ among groups. There was a main effect of MeHg on body weight on PND4 (p = 0.0203 for male and p = 0.0055 for female). Organic and inorganic Hg in neonatal rat brain
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separate models. Data from experiments 1 
and 2 were combined for both outcomes. The 
inclusion of the experiment term in the model 
allows the two experiments to have different 
intercepts. The mixed model includes a ran‑
dom litter effect, which models the correlation 
between pups within a litter and allows the pup 
to be the unit of analysis. This general approach 
was also used by Gray et al. (2009).
We started by treating both MeHg dose 
and Hg vapor dose as continuous variables; 
when the linearity assumption held, we treated 
them as continuous variables in the final 
model. For both outcomes we started by con‑
sidering a full model, which also included all 
two‑way and three‑way interactions among Hg 
vapor dose, MeHg dose, and sex. When the 
three‑way inter  action was not significant, we 
fit a model without this term. We then consid‑
ered models without two‑way interactions and 
without main and/or covariate effects, when 
these terms were not significant.
To satisfy model assumptions, it was neces‑
sary to use a logarithmic (base e) transforma‑
tion of each Hg brain level outcome. For both 
outcomes there was no difference in response 
between low and high Hg vapor dose, so this 
variable could be collapsed into two catego‑
ries: no versus any Hg vapor exposure. Neither 
sex of the pup nor experiment was a signifi‑
cant predictor for either outcome, indicating 
in part that data from both experiments could 
be combined into a single model. For organic 
Hg brain levels, we found a linear relationship 
between the logarithm of organic Hg brain 
levels and the logarithm of MeHg dose (after 
adding 0.l to avoid taking the logarithm of 
0), and our final model included three terms: 
log(MeHg dose + 0.1), any Hg vapor exposure, 
and their interaction. The interaction allows 
the slope relating MeHg dose to organic brain 
Hg outcome to differ for Hg vapor–exposed 
compared with non‑Hg vapor–exposed pups.
For inorganic Hg brain levels, the relation‑
ship to MeHg dose was not quite linear. Our 
final model for this outcome included three 
terms or groups of terms: three indicator vari‑
ables for MeHg dose, any Hg vapor exposure, 
and their interactions. Sex and experiment 
were not significant predictors.
Results
Breeding outcomes. The number of litters and 
number of pups per litter in each group on 
PND1 and PND4 are shown in Tables 2 and 3. 
On PND1, the groups in experiments 1 and 2 
did not differ in litter size (the group average 
varied from 8.7 to 11.9 pups in experiment 1 
and from 8.1 to 11.5 in experiment 2) or in sex 
ratio within a litter (1.07–1.58 and 0.97–2.08 
in experiments 1 and 2, respectively). Body 
weights on PND1 did not differ. The num‑
ber of pups in the 6‑ and 9‑ppm MeHg dose 
groups decreased between PND1 and PND4 in 
experiment 2. Two‑way ANOVA showed that 
MeHg had a main effect on body weight of 
both male (p = 0.0203) and female (p = 0.0055) 
pups on PND4 in experiment 2 but not in 
experiment 1. We found no effects of Hg vapor 
and interaction of MeHg and Hg vapor. 
Hg in dam blood. We compared the 
logarithm of Hg levels (total, inorganic, and 
organic) in blood on GD18 across groups, sepa‑
rately by experiment, as shown in Figure 1. We 
found significant differences among the groups 
(p < 0.0001 for total, inorganic, and organic 
Hg) in both experiments. Two‑way ANOVA 
with interactions showed that in experiment 1, 
the interactions between MeHg and Hg 
vapor were significant for all three outcomes 
(p = 0.0006 for total Hg, p = 0.002 for inor‑
ganic Hg, and p = 0.0002 for organic Hg, each 
for a 3 df test). In experiment 2, the interactions 
were significant for inorganic Hg (p < 0.0001) 
but not for total or organic Hg. MeHg was a 
very strong predictor of total, inorganic, and 
organic Hg in both experiments (p < 0.001). 
With the exception of inorganic Hg in experi‑
ment 2, Hg vapor did not affect Hg levels.
Hg in pup brain. Total, inorganic, and 
organic Hg levels in pup brains for each 
group are summarized in Tables 4 and 5. 
Figure 2 shows the observed (points) and fit‑
ted values (lines) of organic Hg in pup brain, 
where both the brain levels and the MeHg 
dose are on the logarithmic scale. The vapor 
and no‑vapor points are offset slightly in 
Figure 2A for clarity. We found an interac‑
tion of MeHg and Hg vapor on organic brain 
Hg (p < 0.0001; Figure 2A). Among animals 
exposed to Hg vapor, the predicted levels of 
brain organic Hg were larger among animals 
not exposed to MeHg, but organic Hg lev‑
els rose less steeply with increasing MeHg 
exposure compared with those in animals not 
exposed to Hg vapor. Figure 2B shows the 
relationship between organic brain Hg and 
Hg vapor, separately by MeHg concentration. 
As Figure 2 illustrates, organic brain Hg was 
very strongly predicted by MeHg dose.
MeHg was also a very strong predic‑
tor of inorganic brain levels (p < 0.001 for 
each MeHg dose; Figure 3A). The observed 
(points) and fitted values (lines) of inorganic 
Hg in pup brains are shown in Figure 3. For 
inorganic Hg brain levels, we coded MeHg 
dose with three indicator variables to dis‑
tinguish among the four MeHg dose levels. 
This analysis showed interactions between Hg 
vapor and the MeHg dose indicator variables 
(p = 0.02 for the 3 df test).
In summary, the dose of MeHg drove 
levels of both organic and inorganic Hg in 
pup brains. Exposure to Hg vapor lowered 
pup brain Hg levels at high MeHg doses and 
increased them at low MeHg doses com‑
pared with animals not exposed to Hg vapor. 
Separate analysis showed that among the 
40 animals with no MeHg exposure, exposure 
to any Hg vapor (n = 24 animals) was associ‑
ated with a higher brain Hg level compared 
with no exposure to Hg vapor (n = 16 ani‑
mals; p = 0.02 for both organic and inorganic 
Hg; Figure 4).
Discussion
Prenatal exposure to the combination of 
MeHg and Hg vapor had interactive effects on 
the levels of organic and inorganic Hg in rat 
neonatal brain. Surprisingly, Hg levels were 
increased by Hg vapor at low MeHg doses, a 
finding relevant to human exposures, which 
typically occur at low concentrations.
Total Hg concentration in brains of pups 
exposed to 6 ppm MeHg without Hg vapor 
is comparable to that on PND1 in previ‑
ous studies, in which MeHg dose and dura‑
tion of exposure were similar to ours (Day 
et al. 2005; Newland et al. 2006; Newland 
and Reile 1999). In these studies, rat dams 
Figure 1. Concentrations (mean ± SD) of organic Hg (A and C) and inorganic Hg (B and D) in dam blood on 
GD18 from experiment 1 (A and B) and experiment 2 (C and D).
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were exposed daily to MeHg for 30 days or 
longer before breeding, simulating the pre‑
dominant human exposure pattern of a stable 
diet. Although we did not determine whether 
steady‑state levels had been attained in the 
pregnant females, Newland and Reile (1999) 
found no differences in brain Hg levels of 
PND0 offspring of females that had been 
exposed for 28 or 45 days before breeding. 
Baseline Hg concentrations achieved by these 
studies are consistent over time, and thus are 
preferable to short‑term exposures as a basis 
for risk assessments.
Pup brain Hg (total, inorganic, and 
organic) concentrations increased with the 
dose of MeHg, but this increase was not lin‑
ear across the exposure groups. That is, total 
brain and organic Hg concentrations in pups 
exposed to 6 or 9 ppm MeHg were greater 
than two or three times those of pups exposed 
to the lowest MeHg dose (3 ppm). Newland 
and Reile (1999) also found that total Hg in 
pup brain at birth increased nonlinearly with 
the concentration of MeHg (0.5 or 6.4 ppm in 
drinking water) when rat dams were exposed 
to MeHg beginning 28 or 49 days before 
breeding and through gestation, similar to the 
present study design. Such non  linearities have 
also been seen in non  human primates (Lushei 
et al. 1977). The present data suggest that 
extrapolation from high‑concentration expo‑
sures may distort estimates of brain Hg levels 
at lower MeHg doses. The present data also 
suggest that with a logarithmic transformation 
of both pup brain Hg and MeHg dose, a lin‑
ear dose–response relationship may be reason‑
able. The increase in inorganic Hg associated 
with increased MeHg doses was not similar 
to that measured by organic Hg levels. The 
increase seen in total and organic Hg as MeHg 
dose increased was higher between 6 and 9 
ppm MeHg than between 0 and 3 ppm or 
between 3 and 6 ppm, whereas the increase of 
inorganic Hg was lower. This complex pattern 
indicates that attempts to estimate brain levels 
of inorganic Hg on the basis of dose requires 
that experiments rely on the lower MeHg 
exposure levels that are rele  vant to human 
exposure levels.
In these experiments, inorganic Hg in 
pup brain increased with increasing MeHg 
dose. This result is ascribed to the process by 
which MeHg is converted to the inorganic 
form (Clarkson 1997; Clarkson and Magos 
2006). Moreover, elevated levels of inorganic 
Hg have been found in the brains of humans 
and monkeys exposed to MeHg (Davis et al. 
1994; Vahter et al. 1995). One site for the 
process would be phagocytic cells present in 
many mammalian tissues, including the brain, 
that are capable of breaking the carbon–Hg 
bond (Suda and Takahashi 1990). Thus, inor‑
ganic Hg in brain tissue may arise from in situ 
metabolism of MeHg. However, it is still pos‑
sible that some of the inorganic Hg does not 
represent the in situ conversion of MeHg but 
instead is derived from some distant source via 
the vapor pathway. Intestinal micro  flora are 
also capable of cleaving the carbon–Hg bond 
(Rowland et al. 1987). Because the vapor pro‑
duced by reduction of inorganic Hg in the 
intestine or phagocytic cells in the liver readily 
crosses the blood–brain barrier to be oxidized in 
brain tissue (Clarkson 1997), some portion of 
the inorganic Hg in pup brain may arise from 
this process. However, it is not clear whether 
it occurs in the fetus or in the mother. Because 
MeHg readily crosses the placental barrier 
(Vahter et al. 2000), MeHg transferred from 
mother to fetus may be converted to inorganic 
Hg in the fetus. Also, inorganic Hg converted 
from MeHg in the mother may be transferred 
to the fetus via placenta and reach fetal brain 
as non‑ionized Hg, which also crosses the pla‑
cental and blood–brain barrier (Clarkson et al. 
1972; Khayat and Dencker 1982; Yoshida 
2002). Contributions to pup brain inorganic 
Hg may differ between fetus and mother.
Exposure to Hg vapor increased brain Hg 
levels (total, inorganic, and organic) in the 
pups not exposed to MeHg. The increase in 
brain Hg was not related to the concentration 
of Hg vapor, which may suggest that the Hg 
level in the pup brains reached steady state 
before the time of brain sampling. However, 
Morgan et al. (2002, 2006) showed that, in 
the brains of neo  nates perinatally exposed to 
Hg vapor (1, 2, 4, or 8 mg/m3 for 2 hr/day 
during GD6–GD15), total Hg concentrations 
increased with increasing exposure dose. The 
exposure concentrations they employed were 
higher, and the duration shorter, than those 
in the present study, which might contribute 
to the differing results. Although data on the 
elimination of inorganic Hg in the fetus and/
or neo  nate after gestational exposure are sparse, 
factors of retention and/or elimination should 
be considered to evaluate the effect of prenatal 
exposure to Hg vapor on the brain Hg levels 
because of the time lag (6–7 days) between the 
last exposure and the brain sampling. There is 
unlikely to be any loss of inorganic Hg due to 
this process, because the methylation of inor‑
ganic Hg does not appear to take place to any 
Table 4. Total, inorganic, and organic Hg concentrations (mean ± SD) in pup brain on PND4 in experiment 1.
Group [MeHg (ppm) × Hg vapor (µg/m3)]
0 × 0 3 × 0 6 × 0 0 × 300 3 × 300 0 × 1,000 3 × 1,000 6 × 1,000
Total Hg (ng/g)
Males 20 ± 7 2,773 ± 231 8,997 ± 2,949 42 ± 13 2,946 ± 208 50 ± 11 3,244 ± 626 8,064 ± 1,524
Females 26 ± 15 2,723 ± 86 9,262 ± 2,810 43 ± 7 2,928 ± 383 51 ± 14 2,685 ± 571 7,900 ± 2,150
Inorganic Hg (ng/g)
Males 5 ± 0 140 ± 23 490 ± 209 11 ± 5 150 ± 35 18 ± 5 172 ± 37 350 ± 113
Females 7 ± 3 140 ± 15 505 ± 169 13 ± 6 148 ± 30 20 ± 3 151 ± 32 290 ± 149
Organic Hg (ng/g)
Males 15 ± 7 2,632 ± 231 8,507 ± 2,749 31 ± 13 2,796 ± 180 33 ± 7 3,072 ± 593 7,715 ± 1,420
Females 20 ± 12 2,583 ± 101 8,757 ± 2,658 31 ± 4 2,780 ± 359 32 ± 12 2,534 ± 539 7,510 ± 2002
Table 5. Total, inorganic, and organic Hg concentrations (mean ± SD) in pup brain on PND4 in experiment 2.
Group [MeHg (ppm) × Hg vapor (µg/m3)]
0 × 0 3 × 0 6 × 0 9 × 0 0 × 1,000 3 × 1,000 6 × 1,000 9 × 1,000
Total Hg (ng/g)
Males 26 ± 13 3,469 ± 254 8,254 ± 1,078 16,122 ± 4,419 32 ± 8 3,286 ± 321 6,796 ± 1,684 11,795 ± 3,156
Females 29 ± 16 3,703 ± 72 9,703 ± 2,216 16,545 ± 5,941 33 ± 11 3,379 ± 287 6,468 ± 1,727 13,177 ± 5,007
Inorganic Hg (ng/g)
Males 8 ± 6 167 ± 19 452 ± 95 612 ± 52 7 ± 3 160 ± 48 370 ± 75 518 ± 107
Females 8 ± 7 165 ± 18 475 ± 83 678 ± 151 5 ± 0 156 ± 22 366 ± 58 668 ± 203
Organic Hg (ng/g)
Males 18 ± 11 3,302 ± 240 7,803 ± 1,004 15,511 ± 4,376 25 ± 7 3,127 ± 293 6,426 ± 1,622 11,277 ± 3,052
Females 21 ± 15 3,538 ± 62 9,228 ± 2,150 15,867 ± 5,811 28 ± 11 3,223 ± 276 6,102 ± 1,670 12,509 ± 4,812Organic and inorganic Hg in neonatal rat brain
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significant extent in either human or animal 
tissues (Clarkson and Magos 2006).
So far, only one study has addressed pre‑
natal coexposure to MeHg and Hg vapor 
(Fredriksson et al. 1996). That study showed 
that brains of rat offspring (on PND3) pre‑
natally exposed to both MeHg and Hg vapor 
contained more total Hg than those exposed 
to either form alone. Statistical analyses of the 
joint and single contributions of MeHg and 
Hg vapor to total Hg seem not to have been 
performed, although coexposure resulted in 
slightly higher Hg levels in the brain (12 ng/g) 
than what would had been expected, consider‑
ing the concentrations obtained after expo‑
sure to either MeHg (4 ng/g) or Hg vapor 
(5 ng/g) alone. The present data suggest that 
coexposure to Hg vapor slightly lowered brain 
Hg levels at high MeHg doses and increased 
them at low MeHg doses. In the study by 
Fredriksson et al. (1996), the MeHg dose was 
2 mg/kg/day, which is higher than our highest 
dose, which would be approximately 700–
750 µg/kg/day if we extrapolate from Newland 
and Reile (1999). Similarly, Fredriksson et al.’s 
dose of Hg vapor was 1.8 mg/m3 for 1.5 hr/
day, which is also higher than our highest dose 
(1.0 mg/m3 for 2 hr/day). In addition, MeHg 
exposure occurred only during GD6–GD9, 
and that of Hg vapor occurred during GD14–
GD19, which means that the two exposures 
did not occur simultaneously. Different doses 
and duration of exposures might explain the 
different outcomes.
Several metabolic processes could account 
for the observation that exposure to Hg vapor 
lowered brain Hg levels at high MeHg doses. 
Inorganic Hg, but not MeHg, can induce 
the metal‑binding protein metallothionein. 
Binding to this protein is generally regarded 
as a detoxication process (Clarkson 1997; 
Clarkson and Magos 2006) and has been 
proven to play an important role in the reten‑
tion of Hg in tissue. Metallothionein induced 
by Hg vapor in the mother and/or in the fetus 
might prevent MeHg and perhaps inorganic 
Hg from reaching the fetal brain. The conver‑
sion of MeHg to inorganic Hg may also need 
to be considered (Clarkson 1997; Clarkson 
and Magos 2006). Inorganic Hg in the form of 
oxidized Hg has a limited capacity to cross the 
blood–brain and placental barriers (Clarkson 
1997; Clarkson and Magos 2006). The pres‑
ence of large amounts of Hg vapor might pro‑
mote the oxidation of MeHg in the mother 
and/or in the fetus, resulting in less Hg reach‑
ing the brain. However, this hypothesis has not 
yet been tested. 
The main source of human exposure to 
MeHg is the diet, especially fish and seafood 
(U.S. EPA 1997). Dietary intake of MeHg 
is estimated at 0.1–2.0 µg/kg body weight 
per week for numerous national diets (IPCS 
2004). The U.S. EPA’s current reference dose 
for MeHg is 0.1 µg/kg body weight/day (U.S. 
EPA 2001, 2009). The 53rd meeting of the 
Joint Food and Agriculture Organization/
World Health Organization Expert Committee 
on Food Additives established provisional tol‑
erance weekly intake of 200 µg MeHg (3.3 µg/
kg body weight) for the general population but 
noted that fetuses and infants might be more 
sensitive than adults to its toxic effects (IPCS 
2000). Because there has been no definitive 
separation of prenatal and postnatal exposure 
that would permit dose–response modeling, 
there are currently no data that would support 
the derivation of a child (vs. general popula‑
tion) reference dose (U.S. EPA 2001). Those 
values are relatively low compared with doses 
we used in rats in the present study. Rat blood 
has approximately 10 times as much hemoglo‑
bin as does mouse, monkey, or human blood 
(Magos 1987) and binds Hg. That means that 
rat blood has a higher capacity to bind Hg, so 
Figure 2. Organic Hg in pup brain on PND4 by log scale of MeHg (A) and absolute value of Hg vapor (B). 
Data points show individual pups. The fitted values in (A) exhibit a clear linear relationship between 
the logarithm of organic Hg brain levels and the logarithm of MeHg dose. The interaction allows the 
slope relating MeHg dose to organic brain Hg outcome to differ for Hg vapor–exposed compared with 
non‑Hg vapor–exposed pups. Interaction of MeHg and Hg vapor on organic Hg values, p < 0.0001; organic 
brain Hg is strongly predicted by MeHg dose.
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a higher intake is required to compare neo‑
natal brain Hg, a better biomarker, across spe‑
cies (Burbacher et al. 1990). However, the 
present study showed that, at lower MeHg 
doses, exposure to Hg vapor increased both 
brain organic and inorganic Hg levels. In addi‑
tion, the increase in brain Hg did not depend 
on the Hg vapor dose. That means that brain 
Hg levels might be higher than expected even 
if MeHg intake is lower than the provisional 
tolerance weekly intake or U.S. EPA reference 
dose when fetuses are simultaneously exposed 
to Hg vapor even at levels as low as those 
attributable to dental amalgams. This might 
be one mechanism by which coexposure to 
dietary MeHg and Hg vapor at levels relevant 
to human exposure elevates neurotoxic risks 
and may need to be taken into account for risk 
assessment calculations. Additional research is 
required to directly evaluate such outcomes.
Conclusions
Our study has revealed interactive effects of 
joint exposure to MeHg and Hg vapor during 
the prenatal period on organic and inorganic 
Hg levels in pup brain. Hg vapor increased 
both forms of Hg in pup brain at lower MeHg 
concentrations, an outcome rele  vant to human 
exposure. Human fetuses exposed to both 
MeHg and Hg vapor may have increased risks 
of neuro  develop  mental toxicity in contrast to 
either type of Hg alone.
co r r e c t i o n
In the manuscript originally published 
online, right‑hand columns showing higher 
Hg vapor doses were inadvertently omitted 
from Tables 2–5, error bars were omitted 
from Figure 1A and 1B, and Figure 2B was 
incorrect. The tables and figures have been 
corrected here. 
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